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Abstract
Objective: Formaldehyde is still widely employed as a universal crosslinking agent, preservative and disinfectant, despite its
proven carcinogenicity in occupationally exposed workers. Therefore, it is of paramount importance to understand the
possible impact of low-dose formaldehyde exposures in the general population. Due to the concomitant occurrence of
multiple indoor and outdoor toxicants, we tested how formaldehyde, at micromolar concentrations, interferes with general
DNA damage recognition and excision processes that remove some of the most frequently inflicted DNA lesions.
Methodology/Principal Findings: The overall mobility of the DNA damage sensors UV-DDB (ultraviolet-damaged DNA-
binding) and XPC (xeroderma pigmentosum group C) was analyzed by assessing real-time protein dynamics in the nucleus
of cultured human cells exposed to non-cytotoxic (,100 mM) formaldehyde concentrations. The DNA lesion-specific
recruitment of these damage sensors was tested by monitoring their accumulation at local irradiation spots. DNA repair
activity was determined in host-cell reactivation assays and, more directly, by measuring the excision of DNA lesions from
chromosomes. Taken together, these assays demonstrated that formaldehyde obstructs the rapid nuclear trafficking of DNA
damage sensors and, consequently, slows down their relocation to DNA damage sites thus delaying the excision repair of
target lesions. A concentration-dependent effect relationship established a threshold concentration of as low as 25
micromolar for the inhibition of DNA excision repair.
Conclusions/Significance: A main implication of the retarded repair activity is that low-dose formaldehyde may exert an
adjuvant role in carcinogenesis by impeding the excision of multiple mutagenic base lesions. In view of this generally
disruptive effect on DNA repair, we propose that formaldehyde exposures in the general population should be further
decreased to help reducing cancer risks.
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Introduction
In aging populations, the incidence of chemoresistant malig-
nancies continues to rise. For example, the ultraviolet (UV)
radiation of sunlight is a primary risk factor for skin cancer [1]. As
a major interface separating the body from the environment, skin
cells provide an effective barrier against physical and chemical
insults. Besides the photoprotectant melanin, a dedicated nucle-
otide excision repair (NER) activity mitigates the carcinogenicity of
sunlight by excising UV-induced photoproducts from DNA before
they are converted to genetic mutations [2,3]. Another defense
line, known as base excision repair (BER), removes concurrent
oxidative base lesions [3–5]. However, the skin and other tissues
frequently come in contact with chemicals that react with cellular
components like chromatin in the close vicinity of DNA, thus
potentially interfering with DNA-repairing enzymes. Formalde-
hyde is a compound of particular concern because of its ubiquitous
distribution, widespread human exposure and verified human
carcinogenicity. This reactive aldehyde appears in automotive
emissions or tobacco smoke and is added to many industrial and
medicinal products. Formaldehyde-containing resins are used in
the manufacture of plywood, paper, textile fibers, plastics, paints,
lubricants and dyes. Formaldehyde is also employed in furniture,
upholstery, carpeting, drapery and other household products [6–
9]. Cosmetics are another important source as they are often
preserved with formaldehyde donors [10].
At high doses, formaldehyde generates DNA-protein crosslinks
(DPXs) [11,12] and induces nasal carcinomas in rodents [13]. In
view of the documented risk of nasopharyngeal, sinonasal,
lymphatic and hematopoietic cancer in occupationally exposed
workers [14–16], it has been categorized as a human carcinogen
[17,18]. This current classification does not consider formaldehyde
as a possible risk factor for cutaneous cancer, although very
substantial levels of this compound (65% of the dose) are found in
the skin after topical application to experimental animals [19].
This pronounced ability of formaldehyde to penetrate the skin
raises the concern that cutaneous cancer may represent another
adverse endpoint. In an animal model of carcinogenesis, formalde-
hyde exhibits no tumorigenicity by dermal exposure on its own but
nevertheless displays a deleterious effect by dramatically reducing
PLOS ONE | www.plosone.org 1 April 2014 | Volume 9 | Issue 4 | e94149
the latency time of carcinogen-initiated skin tumors [20]. Such an
adjuvant role during the carcinogenesis process, detected in animal
experiments, is also supported by the observation that morticians,
who used formaldehyde as an embalming fluid, display an elevated
mortality due to skin cancer [21].
Previous studies suggested an interference of formaldehyde with
the proper processing of various forms of DNA damage [22,23]. In
the case of global-genome NER activity, the detection of UV
lesions depends on a specific accessory complex, known as UV-
DDB (for UV-damaged DNA-binding), which consists of a
damage sensor (DDB2) and a regulatory subunit (DDB1) [24].
To explore the basis of the observed adjuvant effect in skin
carcinogenesis, we tested how formaldehyde, at non-cytotoxic
concentrations, influences the activity of this critical DNA damage
recognition complex. We thereby identified a novel mechanism by
which NER activity is inhibited in formaldehyde-exposed cells.
Materials and Methods
Expression constructs
The XPC complementary DNA [25] was cloned into pGFP-N3
(Clontech) using the restriction enzymes XmaI and KpnI. The
DDB2 complementary DNA was transferred from pGFP-DDB2-
C1 (Dr. S. Linn, University of California, Berkeley, California) to
pmRFP1-C3 using its BamHI sites. The pGFP-OGG1-C1 vector
was obtained from Dr. P. Radicella, Institut de Radiologie
Cellulaire et Moleculaire, Fontenay-aux-Roses, France, and the
pGFP-APE1-C1 vector from Dr. H. Lans, Erasmus University
Rotterdam, The Netherlands.
Cell culture
All culture media and supplements were from Invitrogen.
Simian virus 40-transformed fibroblasts (GM00637) were obtained
from the Coriell Institute for Medical Research (Camden, NJ).
They were grown in a humidified incubator at 37uC and 5% CO2
using Dulbecco’s modified Eagle’s medium (DMEM) supplement-
ed with 10% heat-inactivated fetal calf serum, 100 units/ml
penicillin G and 100 mg/ml streptomycin.
Transfections
Fibroblasts (,500,000) were seeded into 6-well plates. After
24 h, at a confluence of 80–85%, the cells were transfected with
1 mg expression vector using 4 ml FuGENE HD reagent (Roche).
Following a 4-h incubation, the transfection mixture was replaced
by complete medium and the cells were incubated for another
18 h at 37uC.
Exposures
Solutions of 37% aqueous formaldehyde (Fluka) or acetaldehyde
(Sigma) were each serially diluted in complete medium. All
formaldehyde and acetaldehyde stocks were made fresh and
maintained on ice to prevent evaporation. Cisplatin (cis-diamine-
platinum-II, Sigma) was dissolved in dimethyl sulfoxide. After
transfections, the cells were incubated with fresh complete medium
containing again the indicated concentrations of formaldehyde or
acetaldehyde. For irradiation, the medium was temporarily
removed and the cells were rinsed with phosphate-buffered saline
(PBS) before exposure to UV-C light from a germicidal lamp
(257 nm wavelength). This wavelength results in the formation of
cyclobutane pyrimidine dimers and (6–4) pyrimidine-pyrimidone
photoproducts, which constitute the most prevalent forms of DNA
damage induced by solar light [26].
Protein dynamics
High-resolution fluorescence recovery after photobleaching
(FRAP) analyses were carried out under a controlled environment
at 37uC and with a CO2 supply of 5% using a Leica TCS SP5
confocal microscope equipped with an Ar+ laser (488 nm) and a
636oil immersion lens (numerical aperture of 1.4) as illustrated in
Figure 1A. A region of interest of ,4 mm2 was photo-bleached
for 2.3 s at 80% laser intensity. Fluorescence recovery within the
region of interest was monitored 200 times using 115-ms intervals
followed by 30 frames at 250 ms and 20 frames at 500 ms.
Simultaneously, a reference area of the same size was monitored
throughout all time points to correct for overall bleaching. Finally,
the data were normalized to the pre-bleach intensity.
Chromatin-binding assay
Salt extraction and micrococcal nuclease (MNase) digestion was
used to analyze the binding of UV-DDB to chromatin [25]. After
electrophoretic separation, the samples were transferred to a
polyvinylidene (PVDF) membrane (BioRad) blocked by incubation
for 2 h at room temperature with Tris-buffered saline containing
0.05% (v/v) Tween-20 and 5% (w/v) nonfat dry milk. Antibodies
against the following proteins were used in Western blots: DDB2
(dilution 1:50, ab51017, Abcam), GAPDH (1:49000, No. 4300,
Ambion), H3 (1:109000, No. 07-690, Millipore). HRP-conjugated
secondary antibodies were diluted 10,000-fold. Reactions were
developed with SuperSignal West Pico (Pierce), recorded with a
FUJI LAS-3000 imaging system and quantified using the Quantity
One software (BioRad).
Induction of UV foci
Human fibroblasts were grown on glass cover slips (20 mm
diameter) and transfected with DDB2-EGFP or XPC-EGFP
constructs. After 18-h incubations, the cell culture medium was
removed and the cells were rinsed with PBS. UV foci were
induced by irradiation through the 5-mm pores of polycarbonate
filters (Millipore) using a UV-C source (257 nm, 150 J/m2). After
irradiation, the filters were removed and the cells incubated for
15 min at 37uC in complete DMEM. Immunocytochemistry was
carried out as described [25].
Colony-forming assay
Fibroblasts were treated with formaldehyde as described above,
UV-irradiated at increasing doses, seeded in different dilutions and
incubated in cell culture medium for 7 days at 37uC to allow for
colony formation. Colonies were stained with 0.5% (w/v) crystal
violet in 80% ethanol and counted.
DNA repair assays
The pGL3 and phRL-TK vectors were from Promega. The
pGL3 vector was UV-irradiated (257 nm, 1000 J/m2) on ice in
10 mM Tris-HCl (pH 8) and 1 mM EDTA. Alternatively, pGL3
was incubated with 5.4 mM cisplatin for 24 h at 37uC. The
modified plasmids were recovered by ethanol precipitation. To
generate 8-oxo-29-deoxyguanosine (8-oxo-dG) lesions, pGL3 DNA
was mixed with 2 mM methylene blue and irradiated for 60 min
on ice with visible light using a tungsten lamp (75 W) at a distance
of 20 cm. Subsequently, the dye was extracted with 1% (w/v)
sodium dodecyl sulfate and Tris-EDTA-saturated 1-butanol [27].
Human fibroblasts, grown to a confluence of 80% in 6-well plates,
were transfected with 0.45 mg pGL3 DNA and 0.05 mg phRL-TK.
After a 4-h incubation, the transfection reagent was replaced by
complete medium. The cells were lysed after a further 18-h period
using 0.5 ml Passive Lysis Buffer (Promega) according to the
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manufacturer’s instructions. Photinus and Renilla luciferase activity
was determined in a Dynex microtiter plate luminometer using the
Dual-Luciferase Assay System (Promega). For the assessment of
DNA repair activities, mean values were calculated from the ratios
between Photinus and Renilla luciferase activity [28]. Antibodies
against UV lesions (MBL International) were used in a slot-blot
assay following the manufacturer’s instructions.
Statistical procedures
All results were analyzed with Prism 5 (GraphPad Software)
using the Student’s t-test for comparisons. A value of p,0.05 was
considered statistically significant. The number of independently
repeated experiments (N) is indicated in each figure legend.
Results
Analysis of UV-DDB dynamics in living cells
To test whether formaldehyde disturbs the cellular trafficking of
the critical UV-DDB sensor, we transfected human skin fibroblasts
with a construct that drives the expression of DDB2 conjugated to
enhanced green-fluorescent protein (EGFP). The DDB2-EGFP
fusion, located in the nucleus, was subjected to protein dynamics
studies by FRAP, which is a powerful real-time method to monitor
the in situ mobility of DNA repair subunits in living cells [29–31].
A nuclear area (,4 mm2) of human skin fibroblasts expressing low
levels of DDB2-EGFP is bleached with a 488-nm wavelength laser
that does not produce DNA damage. Subsequently, the replace-
ment of bleached DDB2 molecules with non-bleached counter-
parts, diffusing from surrounding nuclear regions, leads to a
progressive recovery of fluorescence in the target area (Figure 1A).
Besides the diffusion properties of each protein, the rate by which
this fluorescence intensity returns to pre-bleach levels depends on
possible protein associations with DNA, chromatin fibers or
nuclear scaffolds. As the EGFP tag itself undergoes minimal such
interactions [32], the fluorescence signal associated with the
DDB2-EGFP fusion recovers much slower than that of EGFP
alone (Figure 1B).
Although UV-DDB is thought to be required only for the repair
of UV lesions [24,25,30], previous biochemical assays showed that
it also binds to other forms of DNA damage, including base
adducts induced by the antitumor agent cisplatin [33]. To validate
this FRAP assay as a probe of UV-DDB interactions with
chemically induced DNA damage, fibroblasts transfected with
DDB2-EGFP were pre-incubated with 5 mM cisplatin represent-
ing a non-cytotoxic drug concentration [34]. The bleached area
ultimately regained the initial fluorescence intensity within ,25 s,
reflecting rapid movements of EGFP-tagged UV-DDB complexes
within the nuclei. However, cisplatin exposure led to a transient
delay in fluorescence recovery (Figure 1C), indicating that the
nuclear trafficking of UV-DDB is slowed down by interactions
with cisplatin-DNA adducts. From these findings, we concluded
that FRAP provides a suitable method to monitor the interaction
of UV-DDB with chemically damaged chromatin.
Figure 1. Analysis of repair protein dynamics in living cells. (A) A region of interest of ,4 mm2 was photo-bleached and the fluorescence
recovery within this area was monitored over a time frame of 23 seconds. Simultaneously, a reference area of the same size was monitored to correct
for overall bleaching and the resulting data were normalized to the pre-bleach intensity. (B) Quantitative FRAP recordings determined in fibroblasts
transfected with expression vectors coding for the DDB2-EGFP fusion or the EGFP moiety alone (N= 30; error bars, S.E.M.). (C) Recognition of cisplatin-
DNA adducts by UV-DDB revealed by FRAP analyses. Human fibroblasts transfected with the DDB2-EGFP construct were pre-incubated with 5 mM
cisplatin. The resulting FRAP curves were compared with those of untreated controls. Asterisks, statistically significant differences between cisplatin-
treated cells and untreated controls (N = 50; *p,0.05; **p,0.01).
doi:10.1371/journal.pone.0094149.g001
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Reduced UV-DDB trafficking by low-dose formaldehyde
Next, human fibroblasts expressing DDB2-EGFP were exposed
for 18 h to a formaldehyde concentration (75 mM) that was
selected to remain below the cytotoxic range but clearly above the
reported physiological blood content, ranging between 13 and
20 mM [35]. The extended-time treatment was carried out to
reflect the long-term exposure to formaldehyde in the population.
Compared to the untreated control cells, the fluorescence recovery
of DDB2-EGFP was retarded in formaldehyde-treated fibroblasts
(Figure 2A), demonstrating a restrained movement of UV-DDB.
Conversely, the fast fluorescence recovery observed with the
EGFP moiety remained unchanged after formaldehyde treatment
(Figure 2B), implying that interactions between DDB2 itself and
formaldehyde-damaged chromatin are responsible for the reduced
mobility. The same experiment was repeated with acetaldehyde at
concentrations ($3.6 mM) that have been shown to induce at least
as many DPXs as 125 mM formaldehyde [36]. However, even at
the highest dose, acetaldehyde did not interfere with the nuclear
trafficking of UV-DDB (Figure 2C), pointing to a specific DDB2
response to formaldehyde damage. The distinct chemistry of the
covalent linkage, the varying DNA structure at the site of the
linkage or the particular pattern of covalently linked proteins [37]
might explain this different effect of the two crosslinkers.
Because UV-DDB is implicated in DNA repair of UV lesions,
we also monitored its mobility in cells transfected with DDB2-
EGFP and then exposed to UV radiation, or in cells subjected to a
dual treatment with both formaldehyde and UV light. The joint
exposure did not further slow down the DDB2 movements
compared to UV radiation alone (Figure 2D), and this lack of
additive interaction suggests that the binding of UV-DDB to
formaldehyde lesions and UV photoproducts is mutually exclusive.
This view is supported below by the observation that low-dose
formaldehyde hinders UV-DDB from recognizing the UV lesions.
Non-covalent binding to formaldehyde-damaged
chromatin
The FRAP experiments revealed that UV-DDB remains
attached to formaldehyde-damaged chromatin, such that its
nuclear movement is inhibited. To confirm this finding, chromatin
associations were tested biochemically as outlined in Figure 3A.
First, free UV-DDB not bound to chromatin was removed by salt
(0.3 M NaCl) extraction. Second, the resulting nucleoprotein
complexes were solubilized by MNase, which liberates chromatin
by cleavage into short nucleosomal repeats [38]. The fractions of
free proteins (released by 0.3 M salt) and chromatin-bound
proteins (released by MNase digestion) were analyzed using
Figure 2. Delayed nuclear trafficking of UV-DDB. (A) FRAP analysis in human fibroblasts. Cells were transfected with DDB2-EGFP, incubated for
18 h with 75 mM formaldehyde (FA) and analyzed by FRAP (N= 50; error bars, S.E.M.). The fluorescence recovery curves were compared to those of
untreated controls (*p,0.05; **p,0.01). (B) FRAP studies (N = 15; error bars, S.E.M.) demonstrating that EGFP movements are not affected by
formaldehyde (18 h, 75 mM). (C) FRAP analysis with analogous acetaldehyde (AA) treatments (N = 50). (D) Combined formaldehyde and UV treatment.
Transfected human fibroblasts were exposed to 75 mM formaldehyde for 18 h, UV-irradiated (30 J/m2) and subjected to FRAP analysis (N= 30). The
asterisks indicate significant differences between UV-damaged fibroblasts and untreated controls (*p,0.05; **p,0.01).
doi:10.1371/journal.pone.0094149.g002
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antibodies against endogenous DDB2 and different markers to
compare their distribution following each treatment.
Upon exposure of human fibroblasts to increasing doses of UV
light, a growing proportion of the cellular DDB2 pool translocated
to chromatin and essentially all of this chromatin-bound DDB2 is
released by MNase digestion (Figure 3B and 3C). In contrast,
18-h formaldehyde exposures induced a comparably weak binding
of DDB2 to damaged chromatin. Even a 75-mM formaldehyde
treatment, which in the FRAP experiments (Figure 2) reduced
the protein mobility as much as a UV dose of 30 J/m2, resulted in
considerably less chromatin association of DDB2. Importantly, the
residual DDB2 that remained in chromatin after the 0.3 M salt
treatment was completely released, in the absence of MNase
digestion, by high salt (2.5 M NaCl) extraction (Figure 3D).
These biochemical analyses demonstrate, therefore, that the
association of UV-DDB, of which DDB2 constitutes the DNA-
binding subunit, with formaldehyde-damaged chromatin occurs
through transient non-covalent interactions. It is important to note
that standard protocols that employ this reactant as a biochemical
crosslinking agent, for example in chromatin immune-precipita-
tion studies, use nearly 5,000-fold higher concentrations.
Inhibition of XPC trafficking by formaldehyde
We next tested the movement of XPC, a major interaction
partner of UV-DDB [24,25,39]. Unlike other NER factors, XPC
displays a constitutive binding to native DNA that retards its
nuclear dynamics, thus leading to an incomplete fluorescence
recovery even in undamaged cells [31]. Again, FRAP experiments
were performed on nuclear areas of ,4 mm2 in human skin
fibroblasts expressing low levels of XPC-EGFP. The validity of this
approach for monitoring the binding of XPC to chemically
damaged DNA is demonstrated by a 5-mM cisplatin treatment,
whereby the mobility of XPC-EGFP is reduced (Figure 4A)
reflecting its ability to recognize cisplatin-damaged DNA. Unlike
the DDB2 response, however, the dynamics of the XPC complex
is not influenced by 18-h formaldehyde (75 mM) treatments either
alone (Figure 4B) or in combination with UV light (Figure 4C).
A reduction of XPC mobility is nevertheless detected in cells that,
in addition to endogenous DDB2, express ectopic DDB2
conjugated to red-fluorescent protein (DDB2-RFP; Figure 4D).
This finding indicates that the XPC complex is indirectly
immobilized by formaldehyde damage through its association
with UV-DDB. Thus, in view of its low constitutive nuclear
mobility, it is necessary to raise the level of the DDB2 interaction
partner to visualize a sequestration of XPC protein in low-dose
formaldehyde-damaged chromatin.
Impaired recognition of UV lesions
The reduced nuclear trafficking of UV-DDB and XPC indicates
that formaldehyde may hinder recognition of their common
targets. To test this hypothesis, we examined the UV damage
recognition function of UV-DDB and XPC complexes in living
fibroblasts. First, cells expressing low levels of the DDB2-EGFP
construct were UV-irradiated through the pores of polycarbonate
Figure 3. Association of UV-DDB with damaged chromatin. (A) Flow diagram illustrating how chromatin was dissected to monitor the
binding of UV-DDB. Unbound proteins were released by salt (0.3 M NaCl) extraction and the remaining chromatin was solubilized by MNase
digestion. (B) Western blot visualization of the chromatin partitioning of UV-DDB using antibodies against DDB2. GAPDH (glyceraldehyde 3-
phosphate dehydrogenase), marker of unbound proteins; histone H3, marker of chromatin. Human fibroblasts were exposed for 18 h to
formaldehyde or UV-irradiated at the indicated doses. (C) Quantification of three independent binding assays demonstrating the differential
interaction of DDB2 with formaldehyde- and UV-damaged chromatin (error bars, S.D.). (D) Release of chromatin-bound DDB2 and histone H3 by high-
salt extraction. After incubation with 0.3 M NaCl buffer, the chromatin was dissolved with 2.5 M NaCl, thus liberating non-covalently bound
chromatin proteins.
doi:10.1371/journal.pone.0094149.g003
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filters, thus focalizing DNA damage to narrow nuclear spots. After
a 15-min recovery, DNA damage recognition was demonstrated
by recording the co-localization of DDB2, detected by fluores-
cence measurements, and UV lesions detected by immunocyto-
chemistry.
Figure 5A shows that the UV-dependent nuclear redistribution
of DDB2-EGFP induces bright green spots accompanied by a
reduced overall nuclear fluorescence. This pattern reflects an
efficient accumulation of UV-DDB at damaged sites with
concomitant depletion of the protein from undamaged nuclear
regions containing no lesions. In 75-mM formaldehyde-treated
cells, UV-DDB still relocated to UV-irradiated sites, but less
efficiently, resulting in weaker spots of green fluorescence signals
over the surrounding nuclear background (Figure 5B). A similarly
reduced relocation to UV lesion spots was observed in cells
transfected with XPC-EGFP and exposed to formaldehyde
(Figure 5C). The quantitative comparison of three experiments
confirmed that formaldehyde impairs the UV-dependent redistri-
bution of both UV-DDB and XPC, thus inhibiting their
translocation from undamaged nuclear areas to UV-irradiated
sites. In each case, the ratio of fluorescence intensity at UV lesion
spots against the surrounding background was reduced by low-
dose formaldehyde (Figure 5D).
Differential effects on BER enzymes
Another permanent trigger of mutagenesis are oxidative base
lesions such as 8-oxo-dG [3–5]. Therefore, we tested whether
formaldehyde affects the nuclear dynamics of 8-oxo-dG-DNA
glycosylase 1 (OGG1), which initiates BER by recognizing and
removing 8-oxo-dG from DNA leaving apurinic sites. The FRAP
experiments of Figure 6A revealed that, in fibroblasts transfected
with OGG1-EGFP, the fluorescence recovery is delayed upon
incubation with 75 mM formaldehyde, indicating that the consti-
tutive movement of this DNA glycosylase is disturbed by low-dose
formaldehyde. Then, we probed the nuclear dynamics of an
immediately downstream enzyme in the BER pathway, i.e.,
apurinic/apyrimidinic endonuclease 1 (APE1). This follow-up
BER subunit displayed much faster movements in FRAP assays
that were refractory to the 75-mM formaldehyde treatment
(Figure 6B).
Figure 4. Indirect formaldehyde-induced reduction of XPC mobility. (A) Protein dynamics studies of XPC in the nuclei of human fibroblasts.
Cells were transfected with the XPC-EGFP construct, incubated with 5 mM cisplatin and subjected to FRAP analysis (N = 30; error bars, S.E.M.). The
resulting fluorescence recovery curves were compared to those of untreated controls (*p,0.05). (B) FRAP studies (N= 50) demonstrating that the
fluorescence recovery curves of XPC-EGFP are not affected by an 18-h formaldehyde treatment (75 mM). (C) FRAP analysis of transfected fibroblasts
demonstrating that the 18-h formaldehyde treatment (75 mM) does not further reduce the delayed XPC-EGFP trafficking in UV-irradiated cells
(30 J/m2; N = 50). (D) Combined formaldehyde treatment and DDB2 overexpression. The transfected fibroblasts were exposed to 75 mM
formaldehyde for 18 h and subjected to FRAP analysis. The presence of DDB2-RFP resulted in a slightly delayed fluorescence recovery curve of XPC-
EGFP upon formaldehyde exposure (N= 30). Asterisks, significant differences between formaldehyde-treated and untreated fibroblasts (*p,0.05).
doi:10.1371/journal.pone.0094149.g004
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Inhibition of excision activity
Consistent with the compromised mobility of repair factors in
the chromatin context, the low-dose (75 mM) formaldehyde
treatment increased the sensitivity of human fibroblasts to the
cytotoxic effect of UV light (Figure 7A). Next, the fibroblasts were
transfected with a reporter vector (pGL3), carrying the Photinus
Figure 5. Accumulation of damage recognition factors on UV lesions. (A) Representative image illustrating the redistribution of DDB2 to UV
lesion sites visualized with antibodies against (6-4) photoproducts. Human fibroblasts transfected with DDB2-EGFP were UV-irradiated through the
pores of polycarbonate filters and fixed 15 min after treatment. DNA is evidenced by the Hoechst reagent and the nuclei are shown with contrast
images. (B) Representative cells demonstrating the defective translocation of DDB2-EGFP from undamaged nuclear areas to UV lesions after 18-h
incubations with 75 mM formaldehyde. (C) Representative images illustrating that the 75-mM formaldehyde treatment impedes the redistribution of
XPC-EGFP to UV lesions. (D) Reduced fluorescence intensity at UV lesion spots over the surrounding background in cells exposed for 18 h to 75 mM
formaldehyde (N= 54; error bars, S.D.; *p,0.05, **p,0.01).
doi:10.1371/journal.pone.0094149.g005
Figure 6. Formaldehyde-induced damage delays the nuclear trafficking of a DNA glycosylase. (A) Nuclear dynamics of OGG1, the DNA
glycosylase that removes 8-oxo-dG, in human fibroblasts. Cells were transfected with the OGG1-EGFP construct, incubated for 18 h with 75 mM
formaldehyde and subjected to FRAP analysis (N= 50; error bars, S.E.M.). The resulting fluorescence recovery curves were compared to those of
untreated controls (*p,0.05). (B) FRAP studies (N = 50) demonstrating that the extremely fast movements of the APE1-EGFP fusion are not affected
by the 75-mM formaldehyde treatment.
doi:10.1371/journal.pone.0094149.g006
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luciferase sequence, to determine the consequence of low-dose
formaldehyde exposures on transcription and translation. The
measurement of reporter luciferase activity in cell lysates showed
that formaldehyde at concentrations of up to 125 mM exerted no
inhibition on RNA or protein (luciferase) synthesis (Figure 7B).
However, this reporter expression was suppressed by increasing
the formaldehyde concentration to 1 mM, which leads to overt
cytotoxicity.
Next, to monitor the NER pathway, pGL3 reporter vectors
coding for the Photinus luciferase were UV-irradiated and
introduced into fibroblasts together with an undamaged control
coding for Renilla luciferase. DNA repair efficiency was assessed by
measuring the Photinus luciferase activity in cell lysates, followed by
normalization against the Renilla control. In this dual reporter
assay, reactivation of UV-irradiated pGL3 is dependent on the
ability of the NER system to remove UV lesions. The resulting
Photinus/Renilla luciferase ratios revealed that NER activity is
significantly reduced by formaldehyde exposure at 25-mM or
higher (Figure 7C). This low-dose formaldehyde effect provides a
proof for DNA repair inhibition as it reflects diminished
reactivation of the UV-irradiated template rather than reduced
transcription or translation.
The findings of Figure 5 indicated that the inhibition of DNA
repair is caused by an impaired nuclear trafficking of UV-DDB,
resulting in reduced recognition of UV lesions during the NER
process. This view was confirmed by the observation that NER
inhibition could be reversed by co-transfection of the dual reporter
system with a DDB2-EGFP expression vector (Figure 7D). Thus,
by raising the cellular DDB2 level in formaldehyde-treated cells, it
was possible to restore the level of global-genome NER activity to
that found in untreated cells. That the defective recognition
function also jeopardizes the excision of chemically induced DNA
damage is supported by host-cell reactivation assays where the
pGL3 Photinus vector was damaged by cisplatin. Indeed, as a
consequence of the inhibited removal of cisplatin-DNA adducts,
expression of the cisplatin-damaged reporter was reduced by
formaldehyde (Figure 7E). Finally, the induction of oxidative
lesions, instead of UV or cisplatin adducts, in the same reporter
vector demonstrated that also the hindrance of OGG1 mobility,
observed in Figure 6A, translates to a significantly reduced BER
efficiency as measured in host-cell reactivation assays (Figure 7D).
To confirm that an inhibition of DNA repair activity occurs in
the chromosomal context, human fibroblasts were UV-irradiated
after a 75-mM pretreatment with formaldehyde. The excision of
UV lesions from genomic DNA was monitored by a slot-blot
immunoassay taking advantage of antibodies against (6-4) pyrim-
idine-pyrimidone photoproducts (6-4PPs; Figure 8A) or cyclobu-
tane pyrimidine dimers (CPDs). Among the UV lesions induced by
sunlight, 6-4PPs are the ones removed most rapidly from human
cells [40]. In fact, only ,25% of the initial amount of these 6-4PPs
remained in the DNA of untreated control fibroblasts after a repair
time of 3 h. In contrast, formaldehyde-exposed cells displayed a
slower excision activity with only ,50% photoproduct repair
during the same 3-h incubation period (Figure 8B). Similarly, the
low-dose formaldehyde treatment slowed down the excision of
CPDs in human fibroblasts (Figure 8C).
Figure 7. Inhibition of NER and BER activity by low-dose formaldehyde. (A) Colony-forming assay demonstrating that human fibroblasts
exposed to formaldehyde (75 mM) are more sensitive to killing by UV radiation (2 and 5 J/m2) than the respective untreated controls (error bars, S.D.;
n = 3, each measurement in triplicate). The asterisk (*p,0.05) denotes the significantly reduced colony formation ability. (B) Expression of Photinus
luciferase in cells containing undamaged pGL3 and exposed (18 h) to formaldehyde. All values (N = 3; error bars, S.D.) are shown as a percentage of
luciferase activity in untreated fibroblasts. Blank, untransfected cells. (C) Host-cell reactivation of UV-irradiated pGL3 reflecting NER activity in cells
exposed (18 h) to formaldehyde. Values (N= 10; error bars, S.D.) are shown as a percentage of the Photinus/Renilla ratio in control cells. Asterisks,
significant differences from the control (*p,0.05, **p,0.01). (D) Partial restoration of host-cell reactivation in 100-mM formaldehyde-treated cells
overexpressing DDB2-EGFP (N= 5). Asterisk, significantly (*p,0.05) higher NER activity then controls without DDB2-EGFP. (E) Inhibition of host-cell
reactivation of pGL3 containing cisplatin adducts or 8-oxo-dG lesions (N = 5). The asterisks (*p,0.05) denote significantly reduced DNA repair activity
in formaldehyde-treated (75 mM, 18 h) cells.
doi:10.1371/journal.pone.0094149.g007
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Discussion
The human skin is increasingly subjected to UV damage due to
growing leisure times, the popularity of outdoor activities, frequent
traveling to tropical areas and the use of artificial irradiation
devices. Concomitantly, the DNA of the skin or mucous
membranes is constantly attacked by exogenous or endogenous
genotoxins. If not promptly excised by DNA repair machines, the
resulting base lesions give rise to mutations, which in turn may
cause cancer. However, DNA repair systems targeting such
mutagenic lesions are prone to modulation by skin- or mucous
membrane-penetrating xenobiotics. This is the first study that
shows a direct effect of low-dose formaldehyde on the assembly of
NER complexes. A previous report already suggested that
formaldehyde delays DNA repair of UV lesions [23] but this
earlier study was based on indirect measurements whereby
transiently appearing single-stranded DNA breaks were taken as
circumstantial evidence for ongoing excision repair. Another
preceding report [22] revealed an inhibitory effect of formalde-
hyde on unscheduled DNA synthesis, reflecting DNA repair
activity, but at considerably higher concentrations of . 100 mM.
One possible scenario to explain our findings is that formalde-
hyde-induced DPXs are themselves NER substrates that compete
with UV lesions for being repaired. The processing of DPXs is not
completely understood but recent studies concluded that the NER
pathway plays only a marginal role in the removal of DPXs
induced by low-dose formaldehyde [41]. Thus, the delayed NER
activity is unlikely to result from direct substrate competition
between DPXs and UV lesions. As an alternative mechanism, we
hypothesized that the formation of DPXs, mainly histone-DNA
crosslinks, may slow down the molecular search for UV lesions by
DNA damage sensors. It is believed that site-specific DNA-binding
proteins, including DNA repair factors, locate their targets among
the vast excess of non-target DNA by facilitated diffusion. This
search process reduces the dimensionality of protein movements
by ‘‘sliding’’ or ‘‘hopping’’ along DNA filaments [42]. In either
case, the presence of covalently trapped histones or other
chromatin proteins along the DNA path may interrupt such an
effective search mode by facilitated diffusion, thereby restricting
the rate by which DNA lesions are detected and channeled into
DNA repair. This hypothesis was tested by in situ protein
dynamics, thus demonstrating that formaldehyde slows down the
recognition of DNA damage by UV-DDB and XPC. That this
reduced damage recognition efficiency translates to slower repair
has been confirmed by two different tests. In a host-cell
reactivation assay, NER activity was inhibited by formaldehyde
with a 50% reduction at concentrations of 75-100 mM. A NER
inhibition was similarly observed by monitoring the removal of 6-
4PPs and CPDs from the chromosomal DNA of human cells
exposed to 75 mM formaldehyde.
Mechanistically, we found that the observed sequestration of
UV-DDB in formaldehyde-damaged chromatin results from
transient, non-covalent interactions that delay its movements
during the search for DNA damage. Through protein-protein
associations, UV-DDB bound to formaldehyde-damaged chroma-
tin also impedes the function of the XPC complex, such that not
only the excision of UV lesions but also the repair of chemically
induced DNA adducts is diminished. We also found that the
mobility of a representative DNA glycosylase is perturbed by low-
dose formaldehyde and that the ensuing BER pathway is
inhibited. Further dynamic chromatin transactions may be
disturbed by a similar mechanism. For example, Rager et al. [9]
recently reported that formaldehyde perturbs gene expression in
the nasal epithelium.
In conclusion, the compromised DNA repair efficiency,
reported in this study, raises the possibility that frequent exposures
of the skin or mucous membranes to formaldehyde represents an
unexpected additional risk factor for cutaneous cancer in
combination with UV radiation or chemical carcinogens. In a
broader perspective, the inhibition of DNA excision repair activity
by formaldehyde implies that the carcinogenic endpoints of this
highly reactive aldehyde may result, to a great extent, from the
accumulation of DNA adducts and other mutagenic base lesions
induced by constitutively occurring environmental carcinogens or
endogenous genotoxic metabolites. In view of this adjuvant effect,
we expect that a reduction of formaldehyde exposure in the
general population would substantially reduce the overall cancer
incidence.
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Figure 8. Inhibition of UV lesion removal from chromatin. (A)
Untreated or formaldehyde-treated cells (75 mM, 18 h) were exposed to
UV light (10 J/m2) and collected immediately after irradiation or
following 3-h repair incubations. Genomic DNA was isolated and
analyzed for UV lesions using antibodies against 6-4PPs. (B) Quantifi-
cation of three independent experiments demonstrating that 6-4PP
excision is diminished by 75-mM formaldehyde exposure (error bar,
S.D.). The asterisk (*p,0.05) denotes significantly reduced excision in
formaldehyde-treated cells compared to the untreated control. (C)
Quantification of three independent experiments demonstrating that
CPD excision is also inhibited. The asterisks (*p,0.05) denote the
significantly reduced excision in 75-mM formaldehyde-treated cells
compared to untreated controls.
doi:10.1371/journal.pone.0094149.g008
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